Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06869811 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Oral Anticoagulation Versus Left Atrial Appendage Occlusion Added to Direct Oral Anticoagulation in Patients with Stroke Despite Oral

Study acronym: ADDLAAO
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
A total of 380 patients with ischemic stroke despite OAC will be included. Patients will be randomized 1:1 to the best medical treatment (control) or the combination of LAAO and DOAC or OAC. The study's primary endpoint will be the occurrence of a cardioembolic event (ischemic stroke or arterial peripheral embolism) within the first 12 months after inclusion.
Trial Details
NCT Number NCT06869811
Lead Sponsor Hospital Clinic of Barcelona
Collaborators: Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Hospital San Carlos, Madrid, Hospital Álvaro Cunqueiro, Hospital Universitari de Bellvitge, University of Salamanca
Conditions
(from sponsor)		 Left Atrial Appendage Closure
Related terms Stroke
Enrollment 380 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov